SOURCE: The Bedford Report

The Bedford Report

February 17, 2010 13:00 ET Complimentary Investment Analysis on Pfizer, Inc. (NYSE: PFE), AstraZenica plc (NYSE: AZN), Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), Eli Lilly &Co (NYSE: LLY) and Many More

Note to Editors: The Following Is an Investment Opinion Being Issued by the

TORONTO--(Marketwire - February 17, 2010) - The Bedford Report is pleased to announce that its latest Market Update analyzing the Pharmaceuticals Industry has been released. The industry is ready to make noise in the upcoming months, as most expect to see mergers and acquisitions as well as licensing agreements between domestic and foreign drug companies increase. We predict the chances of restrictive national health care reform in the US, and what it could mean for Pharmaceuticals.

We also look at the biggest newsmakers in the industry, and predict which companies are looking strong and which need to make changes to keep up.

Our updated analyst reports on Pfizer, AstraZenica, Rigel Pharmaceuticals, Eli Lilly & Co include:

--  An unbiased view and rating of the company
--  Recent key developments
--  Solid analyst summary -- who's saying what and why?
--  In-depth industry analysis and outlook
--  Major upcoming events to watch out for

Bedford Financial Report works around the clock to provide you with the latest research and analysis to keep you at the forefront of all the latest news in the market so you can make rational investment decisions. Whether you are a beginner, or a seasoned Trader, The Bedford Report can help make you a more aggressive, self reliant profit maker. There's no need to spend money when you can get top quality research for free at

Take the few minutes to register with us at and get access to numerous company reports and industry newsletters and stay abreast of market highlights so you can make the best investment decisions at the right time. Like you, we realize that timing is everything and so we only put out updates and analysis when the markets are ripe for immediate action.

If you are weary of being the last to hear about stirring opportunities and want to know what the others seem to know before you, sign up now for a free membership at has not been compensated by any of the above mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks.

Please view the full disclaimer:

Contact Information